News
Complex protein interactions at synapses are essential for memory formation in our brains, but the mechanisms behind these ...
Proteins are fundamental biomolecules that perform a broad range of vital functions within the human body. They serve as an essential structural and functional component of cells, tissues and organs ...
1d
News-Medical.Net on MSNResearchers simulate protein structures behind learning and memoryOur brain's remarkable ability to form and store memories has long fascinated scientists, yet most of the microscopic mechanisms behind memory and learning processes remain a mystery.
Why do problems occur with a special variant of 'protein glues', the split inteins, that severely limit their use in producing proteins? A team has now answered this question.
Dupixent topped Rx and over-the-counter (OTC) pharma brands for ad impressions during Q1 2025, according to data released by iSpot.tv on Monday afternoon. The Regeneron and Sanofi brand for asthma and ...
You can listen to episodes here. A stroll through almost any major supermarket — where food labels tout grams of protein — bears witness to the trend. And why shouldn’t we be? Along with ...
A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...
Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...
Researchers investigated the quantities of thousands of muscle proteins and found a possible new explanation for muscle memory. A study by the Faculty of Sport and Health Sciences at the ...
Scientists apply principles of math and physics to unravel the mystery of how the endoplasmic reticulum, an organelle vital ...
After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National ...
It also provides Dupixent injection to treat atopic dermatitis ... and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results